Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism p38 MAPK inhibitors(P38 mitogen-activated protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H38N6O3 |
InChIKeyAZFZIUGWRMBKPB-PPOKSSTKSA-N |
CAS Registry1416470-86-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | BR | 08 Oct 2012 |